XML 14 R2.htm IDEA: XBRL DOCUMENT v3.3.1.900
CONSOLIDATED BALANCE SHEETS - USD ($)
Mar. 31, 2015
Dec. 31, 2014
Current assets    
Cash $ 0  
Vacant land deposit
Total current assets
Total Assets $ 0 $ 0
Current Liabilities:    
Accounts payable 89,237 86,633
Accrued expenses 27,288 27,829
Short-term loan - related party 74,998 76,807
Convertible debenture payable, net of premium and discount 191,273 191,273
Accrued interest 27,454 27,454
Line of credit - related party 250,000 250,000
Accrued interest - related party 126,852 126,852
Derivative liability 10,371 10,371
Total Current Liabilities 797,473 797,219
Stockholders' Equity (Deficit)    
Series A convertible preferred Stock, $0.0001 no par value; 200,000 shares authorized, no shares issued and outstanding at March 31, 2015 and December 31, 2014, respectively Series B convertible preferred Stock, $0.0001 no par value; 1,000 shares authorized, 1,000 shares issued and outstanding at March 31, 2015 and December 31, 2014, respectively 2,150 2,150
Common stock, no par value; 1,000,000,000 shares authorized, 28,144,092 and 292,842 shares issued and outstanding at March 31, 2015 and December 31, 2014, respectively 1,012,846 1,012,846
Additional paid-in capital 764,934 764,934
Accumulated deficit (2,577,403) (2,577,149)
Total stockholders' deficit (797,473) (797,219)
Total liabilities and stockholders' deficit $ 0 $ 0
Series A Preferred Stock [Member]    
Stockholders' Equity (Deficit)    
Series A convertible preferred Stock, $0.0001 no par value; 200,000 shares authorized, no shares issued and outstanding at March 31, 2015 and December 31, 2014, respectively Series B convertible preferred Stock, $0.0001 no par value; 1,000 shares authorized, 1,000 shares issued and outstanding at March 31, 2015 and December 31, 2014, respectively
Series B Preferred Stock [Member]    
Stockholders' Equity (Deficit)    
Series A convertible preferred Stock, $0.0001 no par value; 200,000 shares authorized, no shares issued and outstanding at March 31, 2015 and December 31, 2014, respectively Series B convertible preferred Stock, $0.0001 no par value; 1,000 shares authorized, 1,000 shares issued and outstanding at March 31, 2015 and December 31, 2014, respectively $ 2,150 $ 2,150